This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
ROBAXISAL C 1/2
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ROBAXISAL C 1/2 discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ROBAXISAL C 1/2 32.4MG 400MG 325MG has been permanently discontinued (last updated March 2, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ROBAXISAL C 1/2 not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2022-10-10
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
01934791
Strength
32.4MG 400MG 325MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
CODEINE PHOSPHATE METHOCARBAMOL ACETYLSALICYLIC ACID
Tier
Unrated
Last Updated
2022-07-06
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
ROBAXISAL C 1/2 has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.